Company intelligence / Profile preview

Beyotime Biotechnology

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Beyotime Biotechnology is a leading Chinese supplier of life science research reagents, with major strength in cell biology kits (apoptosis, proliferation, protein lysate prep, etc.) and protein/antibody production, serving both academia and biotech industry; no reported therapeutics pipeline

Modalities: Recombinant proteinAntibodySmall molecule (for assay and cell biology reagents, not therapeutics)
Industry: Non-Drug Biotech

Partnerships

Not specified in available results; typical partnerships are with academic life science labs, but not with pharma/biotech for drug development

Beyond the preview

Go deeper on Beyotime Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beyotime Biotechnology.

Explore the full profile